F. Hoffmann-La Roche saw the highest growth of 104% in patent filings and 118% in grants in January in Q1 2024. Compared to Q4 2023, Q1 2024 saw an increase in patent filings by 104% and grants by 118%. GlobalData’s DataBook provides a comprehensive analysis of F. Hoffmann-La Roche’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
F. Hoffmann-La Roche has been focused on protecting inventions in United States(US) with 349 publications in Q1 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 25% filings and 25% grants. The United States(US), European Patent Office(EPO), World Intellectual Property Organization(WIPO), and China(CN) patent Office are among the top ten patent offices where F. Hoffmann-La Roche is filings its patents. Among the top granted patent authorities, F. Hoffmann-La Roche has 25% of its grants in United States(US), 15% in European Patent Office(EPO) and 11% in China(CN).
Johnson & Johnson could be the strongest competitor for F. Hoffmann-La Roche
Patents related to rare diseases and healthtech lead F. Hoffmann-La Roche's portfolio
F. Hoffmann-La Roche has the highest number of patents in rare diseases followed by, healthtech and electronic medical record (emr) systems. For rare diseases, nearly 17% of patents were filed and 19% of patents were granted in Q1 2024.
Healthcare it related patents lead F. Hoffmann-La Roche portfolio followed by image management, and alzheimer's disease
F. Hoffmann-La Roche has highest number of patents in healthcare it followed by image management, alzheimer's disease, breast cancer, and electronic document mgmt. For healthcare it, nearly 6% of patents were filed and 2% of patents were granted in Q1 2024.
For comprehensive analysis of F. Hoffmann-La Roche's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
